洞察市场格局
解锁药品研发情报

客服电话

400-9696-311

医药数据查询

【ChiCTR2000031098】Muscle ultrasonography and frailty in cardiac surgery

查看原文

立即下载

基本信息

登记号

ChiCTR2000031098

试验状态

结束

药物名称

药物类型

规范名称

首次公示信息日的期

2020-03-22

临床申请受理号

靶点

适应症

Cardiovascular disease

试验通俗题目

Muscle ultrasonography and frailty in cardiac surgery

试验专业题目

Correlation between muscle ultrasonographic assessment of rectus femoris and Clinical Frailty Scale in elective cardiac surgical patients

申办单位信息

申请人联系人

请登录查看

申请人名称

请登录查看

联系人邮箱

请登录查看

联系人邮编

联系人通讯地址

请登录查看

临床试验信息

试验目的

The secondary objectives of this study are to: 1. Determine the association between preoperative muscle ultrasonographic assessment on MT, CSA and echogenicity of RF, and physical performance and activity level. 2. Determine the association between preoperative muscle ultrasonographic assessment on MT, CSA and echogenicity of RF, and postoperative outcomes up to 30 days after surgery.

试验分类

请登录查看

试验类型

队列研究

试验分期

诊断试验新技术

随机化

N/A

盲法

N/A

试验项目经费来源

Internal funding of the department

试验范围

目标入组人数

实际入组人数

第一例入组时间

2020-04-01

试验终止时间

2021-05-31

是否属于一致性

入选标准

All adult patients scheduled for elective cardiac surgery admitted to the cardiothoracic surgical ward a day before surgery will be asked to participate in the cohort study. They will be enrolled if written informed consent is made. We will recruit 85 consecutive patients undergoing major elective cardiac surgery, including coronary artery bypass graft, valve surgery or aortic intervention.；

排除标准

We will exclude patients undergoing emergency cardiac surgery, or patients with known musculoskeletal or neurological disorders that are associated with lower limb muscle atrophy (e.g. poliomyelitis, stroke, peripheral neuropathy); previous major surgery at lower extremity (e.g. hip replacement, metal implants at femur); or conditions that influence or are unsuitable for muscle ultrasonographic assessment, such as localised infection, skin disorders or compromised skin integrity, severe edema over thigh, and cognitive impairment (inability to provide consent).；

研究者信息

研究负责人姓名

请登录查看

试验机构

N/A

研究负责人电话

请登录查看

研究负责人邮箱

请登录查看

研究负责人邮编

联系人通讯地址

请登录查看